Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Fibroblasts are a dynamic cell type that achieve selective differentiated states to mediate acute wound healing and long-term tissue remodeling with scarring. With myocardial infarction injury, cardiomyocytes are replaced by secreted extracellular matrix proteins produced by proliferating and differentiating fibroblasts. Here, we employed 3 different mouse lineage-tracing models and stage-specific gene profiling to phenotypically analyze and classify resident cardiac fibroblast dynamics during myocardial infarction injury and stable scar formation. Fibroblasts were activated and highly proliferative, reaching a maximum rate within 2 to 4 days after infarction injury, at which point they expanded 3.5-fold and were maintained long term. By 3 to 7 days, these cells differentiated into myofibroblasts that secreted abundant extracellular matrix proteins and expressed smooth muscle α-actin to structurally support the necrotic area. By 7 to 10 days, myofibroblasts lost proliferative ability and smooth muscle α-actin expression as the collagen-containing extracellular matrix and scar fully matured. However, these same lineage-traced initial fibroblasts persisted within the scar, achieving a new molecular and stable differentiated state referred to as a matrifibrocyte, which was also observed in the scars of human hearts. These cells express common and unique extracellular matrix and tendon genes that are more specialized to support the mature scar.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and resemble POSTN-expressing matrifibrocytes7.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We used an Ang II/PE infusion model to study cardiac fibrosis which has inherent limitations3,4,7,39”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Computational lineage analysis predicted that FAP expression marks a fibroblast trajectory that transitions into populations including POSTN + matrifibrocytes 32 and myofibroblasts.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,406
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
Joe, A. W. B., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., & Rossi, F. M. V. (2010) · Nature Cell Biology · doi:10.1038/ncb2015 · Cited by 1,690
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A., & Kardon, G. (2011) · Development · doi:10.1242/dev.064162 · Cited by 1,249
Darby, I. A., Skalli, O., & Gabbiani, G. (1990) · PubMed · Cited by 1,189
Kajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 5×
“We previously showed that myofibroblasts in the heart can dedifferentiate and revert back to an “uninjured” state after a cardiac stress response resolves, such as with Ang II/PE agonist infusion and then its removal (23).”
BackgroundInfluentialSelf-citationBryant, S. J., & Anseth, K. S. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1217 · Cited by 845
Research works printed but not linked: 1
- 28. Ubil E, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature. 2014;514(7524):585–590. doi: 10.1038/nature13839. · DOI · Paper page
Cited by
Items 401–500 of 638
The JMJD family of histone demethylase and their intimate links to cardiovascular disease
Xie, J., Lin, H., Zuo, A., Shao, J., Sun, W., Wang, S., Jianda, S., Wang, Y., Luo, Y., Sun, J. M., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111046 · Cited by 8
Spatial regulation of substrate adhesion directs fibroblast morphotype and phenotype
D’Urso, M., Jorba, I., van der Pol, A., Bouten, C. V. C., & Kurniawan, N. A. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae289 · Cited by 9
“Our observation of matrifibrocyte-like phenotype in dermal fibroblasts may suggest their more general relevance in maintaining tissue homeostasis in other tissues as well, for example, in the formation and regulation of scars during wound healing, as proposed earlier (38).”
BackgroundInfluentialDirect Cardiac Reprogramming for Cardiovascular Regeneration and Differentiation
Sadahiro, T., & Ieda, M. (2020) · The Keio Journal of Medicine · doi:10.2302/kjm.2019-0008-oa · Cited by 9
Liu, Q., Mukhopadhyay, S., Rodriguez, M. X. B., Fu, X., Sahu, S. P., Burk, D. H., & Gartia, M. R. (2020) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi45749.2020.9098444 · Cited by 8
“Heart tissue sections were processed and obtained following protocols published elsewhere [15].”
MethodSelf-citationCanadian Contributions in Fibroblast Biology
Al‐Hattab, D. S., Chattopadhyaya, S., & Czubryt, M. P. (2022) · Cells · doi:10.3390/cells11152272 · Cited by 10
Phospholipase Cε insufficiency causes ascending aortic aneurysm and dissection
Atchison, D. K., O'Connor, C. L., Converso‐Baran, K., Bergin, I. L., Zhang, H., Wang, Y., Hartman, J. R., Ju, W., Smrcka, A. V., Ganesh, S. K., et al. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00262.2022 · Cited by 11
Gβγ subunits colocalize with RNA polymerase II and regulate transcription in cardiac fibroblasts
Khan, S. M., Martin, R., Bayne, A. N., Pétrin, D., Bourque, K., Jones-Tabah, J., Bouazza, C. A., Blaney, J., Lau, J., Martins-Cannavino, K., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103064 · Cited by 10
Drugging transcription in heart failure
Padmanabhan, A., & Haldar, S. M. (2019) · The Journal of Physiology · doi:10.1113/jp276745 · Cited by 9
“…cardiac remodelling, many of which may originate within non-myocyte cell types (Kanisicak et al. 2016; Khalil et al. 2017; Molkentin et al. 2017; Fu et al. 2018; Honold & Nahrendorf, 2018; Nahrendorf, 2018; Swirski & Nahrendorf, 2018; Valiente-Alandi et al. 2018), have been increasingly…”
BackgroundContreras, O. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00545-3 · Cited by 9
The Cardiac Myofibroblast: From Supporting Cast to Leading Role?
Alexanian, M., & Haldar, S. M. (2018) · Circulation Research · doi:10.1161/circresaha.118.314185 · Cited by 8
Cardiac Fibrosis Mitigated by an Endogenous Negative Regulator of HDAC
Lazaropoulos, M. P., & Elrod, J. W. (2023) · Circulation Research · doi:10.1161/circresaha.123.323211 · Cited by 8
Elevated PRELP expression in heart and liver fibrosis promotes collagen production
Yamauchi, Y., Mieno, H., Suetsugu, H., Watanabe, H., & Nakaya, M. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150785 · Cited by 9
The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis
Psarras, S. (2024) · Biomolecules · doi:10.3390/biom14111403 · Cited by 9
Nagalingam, R. S., Jayousi, F., Hamledari, H., Baygi, D. H., Dababneh, S., Lindsay, C., Geltink, R. I. K., Lange, P. F., Dixon, I., Rose, R. A., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1496884 · Cited by 8
“Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.”
Dressed in Collagen: 2D and 3D Cardiac Fibrosis Models
Cardona-Timoner, M., Gomes, R. N., & Nascimento, D. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073038 · Cited by 9
Wang, Z., Niu, K., Liu, W., Wang, X., Yang, B., Li, T., Chen, Y., Jin, Y., Chen, Y., Lin, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202504552 · Cited by 9
Baba, Y., Maezawa, Y., Kondo, N., Minamizuka, T., Udagawa, H., Ide, S., Ide, K., Teramoto, N., Yamaguchi, A., Kaneko, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-13102-3 · Cited by 7
Fibroblast-Specific Loss of TGF-β Signaling Mediates Lipomatous Metaplasia in the Infarcted Heart
Tuleta, I., Venugopal, H., O’Leary, K., Zheng, D., & Frangogiannis, N. G. (2025) · Circulation · doi:10.1161/circulationaha.125.075676 · Cited by 8
Youness, M., Ekhteraei‐Tousi, S., Nagaraju, C. K., Puertas, R. D., Thienpont, B., Rega, F., Sipido, K. R., & Roderick, H. L. (2025) · Genome Medicine · doi:10.1186/s13073-025-01580-z · Cited by 17
“FB1 has also been shown to lie closer to a TNC + FB state [29] and FB4 to a THBS4 + FB state [24] and to a state classified by its expression of COMP ( identified in artery/tendon tissue ) [44], indicating that it is closer to the previously described matrifibrocyte state [9].”
InfluentialLeveraging Single-Cell Technologies to Advance Understanding of Myocardial Disease
Gardner, R. S., Tucker, N. R., & Amancherla, K. V. (2026) · Circulation Research · doi:10.1161/circresaha.125.326002 · Cited by 10
Cellular and molecular signals of cardiac wound healing after myocardial infarction
Toba, H., Halade, G. V., DeLeon‐Pennell, K. Y., Chiao, Y. A., Yabluchanskiy, A., Nielsen, S. H., Chalise, U., Becirovic‐Agic, M., Brás, L. E. D. C., & Lindsey, M. L. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00891.2025 · Cited by 12
“Myo fi broblasts, which are differentiated fi broblasts, play a key role in this phase, and the majority of fi broblasts at day 7 MI exhibit a myo fi broblast phenotype (148).”
Piątek, P., Pasławski, R., Pasławska, U., Kiczak, L., Płóciennik, M., Janiszewski, A., Michałek, M., Gwizdała, A., Kaźmierczak, J., & Gorący, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185430 · Cited by 8
“In this phase, the fibroblasts become quiescent, and the ECM collagen is cross-linked [25].”
BackgroundPatil, M., Singh, S., Dubey, P. K., Tousif, S., Umbarkar, P., Zhang, Q., Lal, H., Sewell-Loftin, M. K., Umeshappa, C. S., Ghebre, Y. T., et al. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.03.004 · Cited by 9
Zhao, R., Fu, M., Shu, S., Chen, X., Wang, X., Zhang, N., Yang, K., Hua, X., Wang, X., & Song, J. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.01.013 · Cited by 8
Generation of NKX2.5GFP Reporter Human iPSCs and Differentiation Into Functional Cardiac Fibroblasts
López-Muneta, L., Linares, J., Casis, Ó., Martínez-Ibáñez, L., González, A., Bezunartea, J., Nava, A., Gallego, M., Fernández‐Santos, M. E., Rodríguez-Madoz, J. R., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.797927 · Cited by 8
“, 2009) and increeased in adult cFib upon cardiac injury (Kanisicak et al., 2016; Fu et al., 2018)), VIM (an intermediate filament that modulates fibroblast traction force (Ho Thanh et al.”
BackgroundSantos, G. L., DeGrave, A. N., Rehman, A., Disi, S. A., Xhaxho, K., Schröder, H., Bao, G., Meyer, T., Tiburcy, M., Dworatzek, E., et al. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213041 · Cited by 10
Mammalian organ regeneration in spiny mice
Okamura, D. M., Nguyen, E. D., Collins, S., Yoon, K., Gere, J. B., Weiser‐Evans, M. C. M., Beier, D. R., & Majesky, M. W. (2022) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-022-09631-3 · Cited by 9
“similarly reported that the infarct “scar” tissue in spiny mouse hearts is substantially different from the familiar dense collagen-rich fibrotic scar that forms in similarly injured Mus hearts (Koopmans et al. 2021; Fu et al. 2018; Yokota et al. 2020).”
BackgroundA spotlight on fibroblast-activated protein inhibitor (FAPi) cardiovascular imaging
Caobelli, F., & Nappi, C. (2023) · Clinical and Translational Imaging · doi:10.1007/s40336-023-00548-6 · Cited by 7
“Furthermore, an important study featuring mRNA expression profiling showed that distinct signatures of fibroblasts are expressed after MI [29].”
BackgroundRazin, T., Melamed‐Book, N., Argaman, J., Galin, I., Lowy, Y., Anuka, E., Naftali‐Shani, N., Kandel-Kfir, M., Garfinkel, B. P., Brielle, S., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.10.013 · Cited by 9
Self-citationAneurysm Is Restricted by CD34+ Cell‐Formed Fibrous Collars Through the PDGFRb‐PI3K Axis
Wu, H., Yang, X., Chen, T., Yu, B., Chen, M., Wang, T. Z., Jiang, L., Zhang, B., Zhou, X., Cheng, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202408996 · Cited by 12
Charting the cardiac landscape: Advances in spatial transcriptomics for heart biology
Farah, E. N., Diaz, J. T., Bloomekatz, J. E., & Chi, N. C. (2025) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2025.103648 · Cited by 9
Liu, C., Zhou, D., Zhang, Q., Wei, H., Lu, Y., Li, B., Zhan, H., Cheng, J., Wang, C., Yang, Y., et al. (2023) · PeerJ · doi:10.7717/peerj.15841 · Cited by 7
“The transformation from fibroblasts to myofibroblasts mainly occurred four to seven days after MI ( Fu et al., 2018 ).”
Gong, C., Chang, L., Huang, R., Sun, X., Liu, Y., Wu, S., Wang, L., Xu, B., & Wang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107347 · Cited by 6
Piven, O. O., Vaičiulevičiūtė, R., Bernotienė, E., & Dobrzyń, P. (2025) · Acta Physiologica · doi:10.1111/apha.14271 · Cited by 7
“25 During scar maturation, MyoFbs maintain the mechanical structure of the heart tissue but differentiate into matrifibrocytes, the latter of which appear to be critical for maintaining the integrity of the mature scar.”
Elevated phosphate levels in CKD – a direct threat for the heart
Campos, I. D., & Faul, C. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf001 · Cited by 6
Isono, T., Matsumoto, T., Suzaki, M., Kubota, S., Kageyama, S., Kawauchi, A., & Wada, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-26717-7 · Cited by 6
Maroney, S. A., Siebert, A. E., Martinez, N. D., Rasmussen, M. A., Peterson, J. A., Weiler-Guettler, H., Lincoln, J., & Mast, A. E. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2022.11.034 · Cited by 6
Spectrin-Based Regulation of Cardiac Fibroblast Cell-Cell Communication
Nassal, D. M., Shaheen, R., Patel, N., Yu, J., Leahy, N., Bibidakis, D., Parinandi, N. L., & Hund, T. J. (2023) · Cells · doi:10.3390/cells12050748 · Cited by 5
Yogeswaran, A., Troidl, C., McNamara, J. W., Wilhelm, J., Truschel, T., Widmann, L., Aslam, M., Hamm, C. W., Sadayappan, S., & Lipps, C. (2021) · Cells · doi:10.3390/cells10061326 · Cited by 7
“In line with this, lineage-tracing experiments did not exhibit transdifferentiation of fibroblasts to myofibroblasts until days 4–7 after myocardial infarction [27].”
ResultZhang, J., Hu, Q., Jiang, X., Wang, S., Zhou, X., Lu, Y., Huang, X., Duan, H., Zhang, T.-X., Ge, H., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7486726 · Cited by 7
“Furthermore, recent research also demonstrates that the proliferative capacity is clearly diminished when the expression of ACTA2 is downregulated in myofibroblasts [19], indicating that ACTA2 might be a mediator in regulating NSC proliferation.”
BackgroundDeficiency of MMP-10 Aggravates the Diseased Phenotype of Aged Dystrophic Mice
Churio, A. B., Bobadilla, M., Machado, F. J. D., Sáinź, N., Roncal, C., Abizanda, G., Prósper, F., Orbe, J., & Ruiz, A. P. (2021) · Life · doi:10.3390/life11121398 · Cited by 6
“Compared with aged wild-type mice, expression of Cthc1 and Lox was increased in hearts from aged dystrophic mice, and this effect was attenuated by MMP-10 ablation (Figure S4B).”
BackgroundInfluentialGeneration of a novel mouse strain with fibroblast-specific expression of Cre recombinase
Alam, J., Musiime, M., Romaine, A., Sawant, M., Melleby, A. O., Lü, N., Eckes, B., Christensen, G., & Gullberg, D. (2020) · Matrix Biology Plus · doi:10.1016/j.mbplus.2020.100045 · Cited by 7
“Interestingly, these fibroblasts then lose αSMA expression and become quiescent [57].”
BackgroundEditorial: Cardiac Fibrosis, From Lineage Tracing to Therapeutic Application
de Lucia, C., Wallner, M., Corradi, D., & Pironti, G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.641771 · Cited by 6
“The process of cardiac fibrosis can be schematically divided into three phases based on the cell type mainly involved: (i) resident quiescent cardiac fibroblasts inhabit myocardial tissue; (ii) during myocardial injury (MI), fibroblasts differentiate into myofibroblasts, which actively proliferate and secrete ECM unti…”
BackgroundHao, Y., Li, B., Tian, W., Yin, F., & Liu, W. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.120011 · Cited by 5
Ahmad, W., Dutta, S., He, X., Chen, S., Saleem, M. Z., Wang, Y., & Liang, J. (2025) · Bioengineering · doi:10.3390/bioengineering12090940 · Cited by 7
“Furthermore, during the progression of cardiac fibrosis, myofibroblasts may transition into matrifibrocytes with more mature ECM features [41], posing an even greater barrier to reprogramming and warranting further investigation.”
Actin restricts cell proliferation and promotes differentiation during planarian regeneration
Liu, X., Sun, Y., Wang, S., Zhang, S., & Tian, Q. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.008 · Cited by 4
Nguyen, M. T., Imanishi, M., Li, S., Chau, K. M., Banerjee, P., Velatooru, L. R., Ko, K. A., Samanthapudi, V. S. K., Gi, Y. J., Lee, L.-L., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1187490 · Cited by 6
“For instance, inflammation accompanied by increased TGFβ expression can trigger reactivation of endoMT (65, 66), resulting in fibrotic disorders and cardiac fibrosis (29, 67–72).”
BackgroundHunter, C. R., & Hudson, J. E. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02246-3 · Cited by 7
“Compared to myofibroblasts these fibroblasts are POSTN + and are referred to as matrifibro - blasts [ 100].”
Spiroski, A., McCracken, I. R., Thomson, A. J. W., Pinto, M. M., Lalwani, M. K., Newton, K. J., Miller, E., Bénézech, C., Hadoke, P. W. F., Brittan, M., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.953211 · Cited by 5
“As fibroblast proliferation and immune cell activation peak 2–4 days post-MI (15, 29), future investigations of the early post-treatment therapeutic response could identify druggable networks during the acute remodeling window.”
BackgroundSun, C., Bai, M., Jia, Y., Tian, X., Guo, Y., Xu, X., & Guo, Z. (2023) · PeerJ · doi:10.7717/peerj.15736 · Cited by 7
New perspective on the mechanisms of cardiac fibrosis
Wang, H.-F., Du, X., Zhang, Y., & Xiao, H. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.10.009 · Cited by 6
Zhang, W., Zhang, X. Y., Wang, K., Liu, Z., Zhang, L., Liu, S., He, K., Wang, H., Wang, J., Wang, Y., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167655 · Cited by 5
Heart-derived fibroblasts express LYPD-1 and negatively regulate angiogenesis in rat
Sakamoto, S., Matsuura, K., Masuda, S., Hagiwara, N., & Shimizu, T. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.03.010 · Cited by 5
“have reported about the new differentiated phenotype of resident cardiac fibroblasts after myocardial infarction [18].”
BackgroundApplication of genetic cell-lineage tracing technology to study cardiovascular diseases
Sun, X., Lyu, L., Zhong, X., Ni, Z., & Xu, Q. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.03.006 · Cited by 5
Turner, N. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.313280 · Cited by 5
Fibroblast-Cardiomyocyte Interaction in Pediatric Restrictive Cardiomyopathy
Sato, T., & Ito, M. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0100 · Cited by 5
Constanty, F., Wu, B., Wei, K.-H., Lin, I.-T., Dallmann, J., Günther, S., Lautenschlaeger, T., Priya, R., Lai, S.-L., Stainier, D. Y. R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.12.584570 · Cited by 5
Regulation of pathologic fibroblast functions in digestive diseases: a role for hypoxia?
Ohlendieck, C. M., Matellan, C., & Manresa, M. C. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00277.2024 · Cited by 5
Fibroblasts—The emerging therapeutic target of the cardiovascular system?
Asselberghs, S., Halder, M., Kramann, R., & Sluimer, J. C. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100072 · Cited by 4
Zhang, Z., Xie, F.-Q., Cheng, J., Liu, X., Wang, X.-R., Long, J., Feng, Q.-M., & Yuan, D. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1669362 · Cited by 4
Single cell atlas decodes the molecular dynamics of scar repair after human rotator cuff tear
Qin, Y., Yang, G., Zhang, T., Yang, Y., Wan, L., Zhang, T., Wang, L., Hu, Z., Dai, Z., Zhou, H., et al. (2026) · Bone Research · doi:10.1038/s41413-025-00501-5 · Cited by 8
Yazaki, K., Dewar, M. B., Dauz, J. D., Akazawa, Y., Hui, L., Sun, M., Hui, W., Kabir, G., Dejardin, J.-F., Connelly, K. A., et al. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00322.2024 · Cited by 4
Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts
Rudman-Melnick, V., Vanhoutte, D., Stowers, K., Sargent, M. A., Adam, M., Ma, Q., Perl, A. T., Miethke, A. G., Burg, A. R., Shi, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-80930-0 · Cited by 5
Self-citationMyocardial Fibrosis: Cell Signaling and In Vitro Modeling
Graham, C., & Sethu, P. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_10 · Cited by 4
Perish in the Attempt: Regulated Cell Death in Regenerative and Nonregenerative Tissue
Li, S., & Tao, G. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0166 · Cited by 5
“Meanwhile, noncardiomyocytes such as fibroblast and endothelial cells might proliferate in response to cardiomyocyte death, to contribute to fibrosis and angiogenesis (Das et al., 2019; Fu et al., 2018).”
Treatment of Cardiac Fibrosis with Extracellular Vesicles: What Is Missing for Clinical Translation?
Neuber, S., Ermer, M. R., Emmert, M. Y., & Nazari‐Shafti, T. Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310480 · Cited by 4
“have described a subpopulation of cardiac fibroblasts, the matrifibrocytes, that support the mature scar [42].”
BackgroundRegulatory Mechanisms That Guide the Fetal to Postnatal Transition of Cardiomyocytes
Burgon, P. G., Weldrick, J. J., Talab, O. M. S. A., Nadeer, M., Nomikos, M., & Megeney, L. A. (2023) · Cells · doi:10.3390/cells12182324 · Cited by 4
Li, H., Jia, Y., Chen, Z., Yang, L., Ni, L., Cao, Y., Fan, R., Yuan, Z., Zhu, K., Zhang, Z., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-85318-2 · Cited by 4
Zhang, J., Wang, W., Wang, Z., Zhou, M., & Wu, S.-B. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03404-y · Cited by 4
“The fourth paper [15] (strength = 12.47) was by Fu X et al., published in The Journal of Clinical Investigation.”
InfluentialFu, X., Li, C., Liu, Q., & McMillin, K. (2019) · Journal of Animal Science · doi:10.1093/jas/skz111 · Cited by 4
Self-citationTranslational perspectives on cardiac reprogramming
Nam, Y. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.020 · Cited by 4
Nagasaka, A., Terawaki, T., Noda, M., Takashima, M., Fujino, M., Yamauchi, Y., Arawaka, S., Kato, T., & Nakaya, M. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13551 · Cited by 4
Fischesser, D. M., Meyer, E. C., Sargent, M. A., & Molkentin, J. D. (2021) · Journal of Visualized Experiments · doi:10.3791/62023 · Cited by 4
Self-citationBuechler, M., Pradhan, R., Calviello, A. K., Muller, S., Bourgon, R., & Turley, S. (2021) · bioRxiv · doi:10.1101/2021.01.15.426912 · Cited by 3
Correcting dilated cardiomyopathy with fibroblast-targeted p38 deficiencyPreprint
Bretherton, R. C., Reichardt, I. M., Zabrecky, K. A., Goldstein, A. J., Bailey, L. R. J., Bugg, D., McMillen, T. S., Kooiker, K. B., Flint, G. V., Martinson, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.23.523684 · Cited by 7
“unlike changes in fibroblast number these state transitions could resolve or even reverse in 307 response to a DCM specific myocyte targeted therapeutic (51).”
BackgroundTitin cleavage is a driver of cardiomyocyte disengagement and reactive myocardial fibrosisPreprint
López-Unzu, M. Á., Pricolo, M. R., Silva‐Rojas, R., Clemente-Manteca, A., Sánchez-Ortiz, D., Vicente, N., Velázquez-Carreras, D., Morales, C., Gavilán-Herrera, M., Sen-Martín, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.22.645683 · Cited by 4
Minerath, R. A., Kasam, R. K., Swoboda, C. O., Prasad, V., Grimes, K. M., Blair, N. S., Khalil, H., Alfieri, C. M., Eads, L., Saviola, A. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.22.677845 · Cited by 4
Self-citationA patient-specific engineered tissue model of BAG3-mediated cardiomyopathy
Morsink, M. A. J., Wang, B. Z., Watkins, J. M., Zhuang, R. Z., Zhang, X., Chesnais, F., Chen, C., Lock, R. I., Fine, B. M., & Vunjak‐Novakovic, G. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314251371296 · Cited by 4
Bentele, M., Linke, S., Neumüller, S., Korte, A., Gietz, A., Just, A., Stucki-Koch, A., Pfanne, A., Liu, J., Zhao, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-28222-z · Cited by 3
Cardio-Vascular Extracellular Matrix: The Unmet Enigma
PARASKEVAIDIS, I. A., Tsougos, E., & Kourek, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010544 · Cited by 5
“Activation depends on transforming growth factor-β (TGF-β ), interleukin-6 (IL-6), angiotensin II, and endothelin-136 [48], which trigger intracellular signaling mechanisms and promote pro-fibrotic gene expression.”
Periostin contributes to differential sex-linked gene expression during infarct healing
Abual’anaz, B. M., Cayer, L. G. J., Rasul, S. S. H., Rattan, S. G., Lambos, J. C., Evans, T. I. M., Rabinovich-Nikitin, I., Kirshenbaum, L. A., Kienesberger, P. C., Wigle, J. T., et al. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00675.2025 · Cited by 4
Cardiac fibroblast heterogeneity in cardiac fibrosis implication for cell-type-specific treatment
Gu, K., Song, D., & Chen, J. H. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1740147 · Cited by 3
From cells to niches: Rewiring cardiovascular disease through spatial immunity
Xie, C., Shu, X., Wu, Y., & Tian, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116731 · Cited by 3
The Spectrum of Fibroblast Immune Biology
Guarnieri, A., & Turley, S. J. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083024-035801 · Cited by 5
Nguyen, D. C., Stephan, J., Luque, L. G., Brainard, R. E., Brittian, K. R., Wells, C., Teer, M. S., Martinez‐Ondaro, Y., Gouwens, K. R., Little, D. T., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73646-4 · Cited by 4
“9 – 13).”
Connexin43 in Post-Surgical Peritoneal Adhesion Formation
Chua, J. W., Thangaveloo, M., Lim, D. X. E., Madden, L. E., Phillips, A. R. J., & Becker, D. L. (2022) · Life · doi:10.3390/life12111734 · Cited by 4
In Vitro Assessment of Cardiac Fibroblast Activation at Physiologic Stiffness
Goldsmith, R. S., Tsan, Y.-C., Scissors, R. E., Helms, A. S., & Brody, M. J. (2024) · Current Protocols · doi:10.1002/cpz1.1025 · Cited by 3
“Cardiac fibroblasts have gained recognition as crucial cellular regulators that contribute to both normal cardiac function and disease progression (Fu et al., 2018; Ivey & Tallquist, 2016; Kanisicak et al., 2016; Tallquist & Molkentin, 2017).”
BackgroundGLIPR2 regulates EndoMT and cardiac fibrosis after AMI via PDGFRL/AKT/mTOR signaling pathway
Yuan, S., Yang, S., Guo, Y., Huang, Z., Li, W., Meng, C., Xie, Y., Li, S., Chen, X., Long, H., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123816 · Cited by 2
Sipa1 Drives a Maladaptive Fibroblast-Myeloid Axis After Myocardial Infarction
Ko, S., Liu, X., Taniguchi, Y., Ichihara, G., Komuro, J., Yamakawa, H., Shirakawa, K., Hashimoto, H., Katsumata, Y., Endo, J., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.326030 · Cited by 4
Nong, Y., Guo, Y., Ou, Q., Gumpert, A. M., Tomlin, A. A., Zhu, X., & Bolli, R. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04561-7 · Cited by 3
“Genetic lineage tracing revealed that cardiac fibroblasts are activated and proliferate during the first week after MI in mice [5, 44], and differentiate into myofibroblasts, the major cell type that contributes to ECM and fibrotic scar formation, at 4–7 days post-MI [1, 5, 44, 45].”
BackgroundInfluentialIntegrins in Cardiac Form, Function, and Disease
Manso, A. M., Romaine, A., Christensen, G., & Ross, R. S. (2023) · Biology of extracellular matrix · doi:10.1007/978-3-031-23781-2_4 · Cited by 3
68Ga-FAPi: Pathways and Diagnosis in Cardiac Imaging
Popescu, C. E., Ferro, P., Gotuzzo, I., Burger, I. A., Rominger, A., & Caobelli, F. (2023) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-023-09583-3 · Cited by 3
“Consistent with this concept, there is evidence that distinct signatures of fibroblasts are expressed after AMI [49].”
BackgroundThe Effect of Differentiated Learning on Improving Student Learning Outcomes
Aguanda, Setiawan, A., Anwar, M. S., Wardana, M. R. F., & Yambasu, R. A. (2023) · Delta-Phi Jurnal Pendidikan Matematika · doi:10.61650/dpjpm.v1i1.199 · Cited by 20
“Because the thing of mathematics study is abstract (Pozdeyev, 2018; Varum, 2011), many students find it difficult to understand material mathematics (Chen, 2018; Francis, 2015), especially in student vocational school (Fu, 2018; Landa, 2016), Which generally still has low reasoning.”
BackgroundHarnessing stem cell and lineage reprogramming technology to treat cardiac fibrosis
Zeng, N., Tang, W., Wu, Y., Fan, H., Xie, S., & Cao, N. (2023) · Cell Regeneration · doi:10.1186/s13619-023-00182-7 · Cited by 5
“The activation of resident interstitial cell populations and other cell types such as cardiomyocytes and macrophages primarily drive the proliferation of activated myofibroblasts after myocardial injury (Brown et al. 2005; Frangogiannis 2012; Fu et al. 2018; Hinz 2010).”
Background[68Ga]Ga-labeled FAPI Conjugated with Gly-Pro Sequence for PET Imaging of Malignant Tumors
Shang, Y., Zhang, G., Yao, X., Lai, C., Wang, F., Zeng, B., Liu, E., Yuan, H. S., Cheng, Z., & Jiang, L. (2024) · Molecular Imaging and Biology · doi:10.1007/s11307-024-01935-9 · Cited by 3
Eadie, A., Titus, A. J., & Brunt, K. (2018) · American Journal of Physiology. Heart and Circulatory Physiology · doi:10.1152/ajpheart.00381.2018 · Cited by 3
“(6), the authors began to map both the temporality and spatial localization of fibroblast and myofibroblast phenotypes and gene expression.”
BackgroundLiu, C., Medina, P., Thomas, D., Chen, I. Y., Sallam, K., Sayed, D. H., & Sayed, N. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100556 · Cited by 4
“Under pathophysiological conditions, FBs become proliferative and synthesize extracellular matrix that result in scar formation and fibrosis (Fu et al., 2018; Sayed et al., 2013).”
BackgroundSound and Fibroblast Activation Protein Inhibitor
Thackeray, J. T. (2020) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.011603 · Cited by 3
Fibroblasts, myofibroblasts and cardiac arrhythmias
Frangogiannis, N. G. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.37 · Cited by 2
“In vivo , connexin 43 loss did not affect coupling, organ excitation, and arrhythmia generation.”
BackgroundFast skeletal myosin binding protein-C expression exacerbates dysfunction in heart failure
McNamara, J. W., Song, T., Alam, P., Baby, A., Binek, A., Ananthamohan, K., Singh, R. R., Nieman, M. L., van den Berg, M., Cernyar, B., et al. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-026-01202-8 · Cited by 2
“These alterations include activation of fetal [26, 33], pro-fibrotic [7, 44], immune [1, 22, 41], and pro-hypertrophic [10, 43] programs.”
Self-citation
Metadata
- Authors
- Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., & Molkentin, J. D.
- Affiliations
- Louisiana State University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-04-16
- Volume
- 128
- Issue
- 5
- Pages
- 2127-2143
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5957472
- OpenAlex
- W2800350399
- Cited by
- 636
- References
- 54
- Citations by year
- 2026: 58 · 2025: 81 · 2024: 71 · 2023: 93 · 2022: 87 · 2021: 86 · 2020: 90 · 2019: 52 · 2018: 17
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institutes of Health (R01 HL142217)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Keywords
- cardiac fibroblasts, myocardial infarction, scar formation, myofibroblasts, fibroblast differentiation, lineage tracing, extracellular matrix, smooth muscle actin, collagen, cardiac remodeling, wound healing
- MeSH terms
- Animals, Cell Differentiation, Cicatrix, Extracellular Matrix, Female, Humans, Male, Myocardial Infarction, Myocardium, Extracellular Matrix Proteins, Myoblasts, Cardiac, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.